NANO4TARMED: Advanced hybrid theranostic nanoplatforms for an active drug delivery in the cancer treatment - Catrin

NANO4TARMED: Advanced hybrid theranostic nanoplatforms for an active drug delivery in the cancer treatment

Horizon 2020 – REA
Project number: H2020-WIDESPREAD-2020-5: 952063

Principal investigator: RNDr. Václav Ranc, Ph.D.

Funding: 745 000 EUR
Project website: https://nano4tarmed.com/
Implementation period: 01/2021-12/2023